Oneinforty’s Founder & Executive Director Lauren Corduck inherited a BRCA1 gene mutation, which caused her to develop stage four ovarian cancer that was caught by accident in early 2017.
Most Ashkenazi Jews (i.e., Jews of central and Eastern European descent) have little to no knowledge of their one-in-forty risk of inheriting a BRCA gene mutation. If you have a BRCA gene mutation, you are at much higher risk than the general population of developing ovarian, prostate and male and female breast cancer and each of your biological children have a 50 percent chance of inheriting your BRCA gene mutation.
While undergoing ovarian cancer treatment, Lauren launched Oneinforty, a nonprofit organization that is dedicated to stopping BRCA cancer in its tracks. To advance this mission, Oneinforty raises Ashkenazi Jews’ awareness of their risk of inheriting cancer-causing BRCA gene mutations and provides the support individuals and families need to face this risk, make sound personal medical decisions, prevent cancer and detect cancer early.
Oneinforty has a two-pronged approach to raising Ashkenazi Jews’ awareness of inherited BRCA gene mutations:
- We hold educational symposia
- We spread the word via social media and traditional media relations
- We provide professional emotional support
According to the NIH’s National Cancer Institute, “Several options are available for managing cancer risk in individuals who have a known BRCA1 or BRCA2 mutation. These include enhanced screening, prophylactic (risk-reducing) surgery and chemoprevention.”